ClinicalTrials.Veeva

Menu

SPIRA™-A 3D and HCT/p DBM vs. Medtronic Divergent™-L/Perimeter™ and Recombinant BMP-2

C

Camber Spine Technologies

Status

Unknown

Conditions

Degenerative Disc Disease
Spondylolisthesis
Scoliosis
Spinal Stenosis

Treatments

Device: ALIF

Study type

Interventional

Funder types

Industry

Identifiers

NCT04566874
SPA-2018

Details and patient eligibility

About

A prospective, randomized, controlled clinical evaluation utilizing the SPIRA™ ALIF 3-D printed titanium interbody device with DBM vs a Medtronic PEEK ALIF interbody device with BMP

Full description

This is a single blinded randomized 1:1, controlled, prospective clinical study to evaluate fusion status and patient reported outcomes in circumferential lumbar fusion between L2-S1 at a single level with posterior screw fixation (Camber Spine Orthros System) and anterior surgery consisting of one of the treatment groups: subjects treated with the SPIRA™-A Interbody Device and HCTP/p DBM or subjects treated with Medtronic Divergent-L or Perimeter™ PEEK ALIF Interbody Device and rhBMP-2 (6mg per level).

Enrollment

100 estimated patients

Sex

All

Ages

22 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • skeletally mature adults
  • completed 6 month non-operative or conservative therapy
  • signed informed consent
  • back pain with radicular symptoms as evidenced by leg pain
  • Degenerative Disc Disease involving a single level between L2 and S1
  • subject willing to participate in study and follow protocol
  • subject willing to comply with Post-op management program

Exclusion criteria

  • systemic infection such as AIDS, HIV or Active hepatitis
  • autoimmune disease
  • significant metabolic disease that might compromise bone growth
  • history of malignancy
  • previous surgery for primary tumor, trauma or infection
  • subject requires 2 or more levels of fusion
  • previous spinal instrumentation or previous interbody fusion at involved level
  • spondylolisthesis of grade greater than/equal to 2

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Spira-A with HCT/p DBM
Other group
Description:
Single level Spira-A 3D printed Titanium ALIF Device with HCT/p DBM
Treatment:
Device: ALIF
Medtronic PEEK ALIF with Infuse
Active Comparator group
Description:
Single level Medtronic Divergent-L/Perimeter PEEK ALIF Device with Recombinant Bone Morphogenic Protein-2 (Infuse)
Treatment:
Device: ALIF

Trial contacts and locations

2

Loading...

Central trial contact

Noel Hetrick; Donald W Guthner, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems